Ftse Mib
36.218,98
-0,69%
DAX
21.428,24
-1,30%
S&P 500
5.994,57
-0,76%
NASDAQ
19.391,96
-1,20%
Bitcoin
100.339,23
-1,07%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vaccinex Inc (VCNX) Vaccinex Inc (VCNX) Notizie

Vaccinex Inc

VCNX
1,41
0,00 (0,00%)
03 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202415:32EDGAR2Form 8-K - Current report
17/12/202415:00GLOBEVaccinex Announces Receipt of Delisting Notification from..
18/11/202422:15EDGAR2Form SC 13D/A - General Statement of Acquisition of..
18/11/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202414:30GLOBEVaccinex Reports Third Quarter 2024 Financial Results and..
14/11/202423:00EDGAR2Form 8-K - Current report
14/11/202422:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202421:39EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202414:30GLOBEVaccinex Provides Update on ActivMAb® Platform: Multiple..
05/11/202414:30GLOBEVaccinex Reports Improved Immunity Correlating with Clinical..
31/10/202415:00GLOBEVaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial..
25/10/202422:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
24/10/202414:30GLOBEVaccinex to Report Promising New Efficacy Data for SIGNAL-AD..
16/10/202422:44EDGAR2Form S-3 - Registration statement under Securities Act of..
09/10/202422:37EDGAR2Form 8-K - Current report
20/9/202423:15EDGAR2Form SC 13D/A - General Statement of Acquisition of..
20/9/202422:57EDGAR2Form SC 13D/A - General Statement of Acquisition of..
20/9/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202414:30EDGAR2Form 8-K - Current report
18/9/202414:30GLOBEVaccinex Announces Exercise of Warrants for $6.2 Million in..
13/9/202422:16EDGAR2Form 8-K - Current report
20/8/202412:04EDGAR2Form 8-K - Current report
14/8/202423:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202414:35EDGAR2Form 8-K - Current report
14/8/202414:30GLOBEVaccinex Provides Update on New Findings for SIGNAL-AD Phase..
13/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:10EDGAR2Form SC 13D/A - General Statement of Acquisition of..
07/8/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:12EDGAR2Form SC 13D/A - General Statement of Acquisition of..
01/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202415:05EDGAR2Form 8-K - Current report
31/7/202415:00GLOBEVaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2..
17/7/202414:00GLOBEVaccinex to report topline data for SIGNAL-AD Phase 1b/2..
08/7/202422:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/6/202414:36EDGAR2Form 8-K - Current report
06/6/202414:30GLOBEVaccinex Reports Completion of Last Patient Visit in..
31/5/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202400:00GLOBEVaccinex Reports First Quarter 2024 Financial Results and..
15/5/202423:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202418:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202423:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/5/202422:16EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 1,41

La tua Cronologia

NASDAQ
VCNX
Vaccinex
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci